A 35-year-old Aboriginal woman from a remote Northern Territory community has a history of acute rheumatic fever with residual moderate mitral regurgitation. She is often away from community for cultural obligations and misses appointments. Which strategy is most important to reduce her risk of progression of rheumatic heart disease?